rmm7fdhg | Knowledge4COVID-19

Property	Value
?:abstract	There is currently no proven effective therapy for COVID-19. Without wishing to be exhaustive, the drugs most studied in this regard are presented below. Each of the listed therapeutic options is considered experimental at this stage. However, given the severe public health implications of the epidemic and the potentially fatal outcome of COVID-19 patients treated in the intensive care unit, their use \'off-label\' should be considered. Orv Hetil. 2020; 161 (17): 685-688.
?:creator	<https://research.tib.eu/covid-19/entity/F%C3%A1bi%C3%A1n%2C_%C3%81kos%3B_L%C3%A1szl%C3%B3%2C_Istv%C3%A1n%3B_Juh%C3%A1sz%2C_Marianna%3B_Berh%C3%A9s%2C_Mariann%3B_V%C3%A9gh%2C_Tam%C3%A1s%3B_Koszta%2C_Gy%C3%B6rgy%3B_Moln%C3%A1r%2C_Csilla%3B_F%C3%BClesdi%2C_B%C3%A9la>
?:doi	10.1556/650.2020.31812
?:doi	<https://research.tib.eu/covid-19/entity/10.1556/650.2020.31812>
?:journal	Orvosi_hetilap
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/32324361>
?:pmid	32324361
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	[Pharmacotherapeutic options for SARS-CoV-2 infection / COVID-19].
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-04-01

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/rmm7fdhg>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/rmm7fdhg>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all